96
Participants
Start Date
August 14, 2024
Primary Completion Date
June 30, 2026
Study Completion Date
June 14, 2026
Desmopressin (DDAVP)
Patients in the intervention group will receive desmopressin 0.3ug/kg administered as an intravenous infusion 1h before the proposed procedure
Sodium Chloride
Patients in the control group will receive sodium chloride 0.9% 100mL administered as an intravenous infusion 1h before the proposed procedure
Hospital de Clinicas de Porto Alegre, Porto Alegre
Hospital de Clinicas de Porto Alegre
OTHER